E Fund Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-25,992
| Closed | -$55.4K | – | 400 |
|
|
2024
Q4 | $55.4K | Buy |
25,992
+5,629
| +28% | +$12K | ﹤0.01% | 387 |
|
|
2024
Q3 | $57K | Sell |
20,363
-4,970
| -20% | -$13.9K | ﹤0.01% | 349 |
|
|
2024
Q2 | $59K | Sell |
25,333
-11,797
| -32% | -$27.5K | ﹤0.01% | 314 |
|
|
2024
Q1 | $166K | Buy |
+37,130
| New | +$166K | 0.01% | 356 |
|
|
2023
Q4 | – | Sell |
-40,325
| Closed | -$128K | – | 309 |
|
|
2023
Q3 | $128K | Sell |
40,325
-736
| -2% | -$2.34K | 0.01% | 274 |
|
|
2023
Q2 | $204K | Buy |
41,061
+2,624
| +7% | +$13K | 0.02% | 277 |
|
|
2023
Q1 | $190K | Sell |
38,437
-1,208
| -3% | -$5.97K | 0.01% | 305 |
|
|
2022
Q4 | $249K | Buy |
39,645
+8,037
| +25% | +$50.5K | 0.02% | 260 |
|
|
2022
Q3 | $341K | Buy |
31,608
+6,602
| +26% | +$71.2K | 0.03% | 215 |
|
|
2022
Q2 | $285K | Sell |
25,006
-3,309
| -12% | -$37.7K | 0.03% | 242 |
|
|
2022
Q1 | $258K | Buy |
+28,315
| New | +$258K | 0.01% | 248 |
|